RSS0393 ointment for plaque psoriasis
Part of Immune system & allergy, Skin clinical trials.
This trial tests an ointment called RSS0393 for people with plaque psoriasis. It aims to see if the ointment is safe and effective in reducing psoriasis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have had plaque psoriasis for at least 6 months.
- Your psoriasis covers 2% to 20% of your body surface area.
- You are not pregnant, breastfeeding, or planning to become pregnant or donate sperm/eggs during the study and for 8 weeks after.
- You do not have other types of psoriasis, active infections, serious health conditions, or a history of certain cancers or mental health issues.
- Your lab tests (blood count, liver/kidney function) and heart EKG must be within study limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
This study tests a new ointment called RSS0393 in children and teenagers aged 6 to 17 who have plaque psoriasis. The goal is to see if the ointment is safe and how it works in the body. This may offer a new treatment option for those whose psoriasis has not cleared with other treatments.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
Hear when a new Psoriatic Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.